Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Systemic lupus erythematosus | R-HSA-977105 | map05322 | mifepristone | 55245 | drug-path |
Tight junction | R-HSA-2134514 | map04530 | mifepristone | 55245 | drug-path |
Long-term potentiation | R-HSA-9620244 | map04720 | mifepristone | 55245 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | mifepristone | 55245 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | mifepristone | 55245 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | mifepristone | 55245 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | mifepristone | 55245 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | mifepristone | 55245 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | mifepristone | 55245 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | mepyramine | 4992 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | mepyramine | 4992 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | mepyramine | 4992 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | mepyramine | 4992 | drug-path |
Complement and coagulation cascades | R-HSA-114591 | map04610 | mepyramine | 4992 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | mepyramine | 4992 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | mepyramine | 4992 | drug-path |
Cell cycle | R-HSA-1640170 | map04110 | mepyramine | 4992 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | mepyramine | 4992 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | mepyramine | 4992 | drug-path |
Complement and coagulation cascades | R-HSA-114591 | map04610 | desipramine | 2995 | drug-path |